纳米生物融合快报

Scopes Nano-Bio Convergence Letters (NBCL) welcomes original contributions spanning a broad range of topics within nano-bio convergence, including but not limited to: Nanomedicine & Drug Delivery: Design and application of nanocarriers, targeted delivery systems, and theranostic platforms. Bionanotechnology: Integration of biomolecules with nanomaterials for biosensing, diagnostics, and biocatalysis. Nano-Bio Interfaces: Surface functionalization, bio-nano interactions, biocompatibility, and toxicity assessment. Nano-Enabled Diagnostics: Development of nanoscale biosensors, imaging agents, and lab-on-a-chip systems. Tissue Engineering & Regenerative Medicine: Use of nanomaterials and scaffolds for tissue regeneration and organoid development. Environmental Nanobiotechnology: Nanoscale solutions for bioremediation, pollution detection, and sustainable agriculture. Artificial Intelligence in Nano-Bio Research: Machine learning and computational modeling for nano-bio system design and analysis. Nano-Neurotechnology: Nanoscale tools and interfaces for neural recording, stimulation, and brain-machine interfaces. Quantum Biology & Nanoscale Phenomena: Quantum effects in biological systems and their exploitation through nanotechnology. Ethical, Legal, and Social Implications (ELSI): Societal impact, regulatory frameworks, and ethical considerations in nano-bio convergence.